AwesomeCapital
Friday, May 31, 2019
Acadia Pharmaceuticals target hiked by Raymond James
To $43 from $40, maintaining Strong Buy.
https://www.benzinga.com/stock/ACAD/ratings
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.
‹
›
Home
View web version
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.